Hobin Yang
Impact in
-
- Cancer Genomics and Diagnostics
-
- PARP inhibition in cancer therapy
- Cancer Cells and Metastasis
- Lung Cancer Research Studies
- Colorectal Cancer Treatments and Studies
Papers in
- Oncology 7
- Cancer Cells and Metastasis 2
- PARP inhibition in cancer therapy 2
- CAR-T cell therapy research 1
-
- Protein Degradation and Inhibitors 2
- Co-authors
- Young Kee Shin (10 shared papers)Juan He (1 shared paper)Naixin Liang (1 shared paper)Hui Ren (1 shared paper)Lifen Ren‐Heidenreich (1 shared paper)Yifang Zhu (1 shared paper)Wei Wang (1 shared paper)Yanying Zheng (1 shared paper)
- Journals
- Cancer Research and Treatment (2 papers)Cancer Research (2 papers)Pharmaceuticals (2 papers)Laboratory Investigation (1 paper)Frontiers in Oncology (1 paper)
- Partner nations
- South KoreaEthiopiaChina
In The Last Decade
Hobin Yang
14 papers receiving 370 citations
Peers
Comparison fields: 5 of 50
- Cancer Research 91
- Oncology 138
- Pulmonary and Respiratory Medicine 161
- Molecular Biology 132
- Immunology 36
Countries citing papers authored by Hobin Yang
This map shows the geographic impact of Hobin Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hobin Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hobin Yang more than expected).
Fields of papers citing papers by Hobin Yang
This network shows the impact of papers produced by Hobin Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hobin Yang. The network helps show where Hobin Yang may publish in the future.
Co-authors
The 25 scholars most cited alongside Hobin Yang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 179 | |
| 2 | 2022 | 60 | |
| 3 | 2021 | 50 | |
| 4 | 2020 | 29 | |
| 5 | 2009 | 12 | |
| 6 | 2022 | 12 | |
| 7 | 2019 | 9 | |
| 8 | 2021 | 6 | |
| 9 | 2021 | 6 | |
| 10 | 2022 | 3 | |
| 11 | 2024 | 2 | |
| 12 | 2022 | 2 | |
| 13 | 2025 | 1 | |
| 14 | 2025 | 1 |
About Hobin Yang
Hobin Yang is a scholar working on Oncology, Molecular Biology, Radiology, Nuclear Medicine and Imaging, Cancer Research and Pulmonary and Respiratory Medicine, having authored 14 papers that have together received 372 indexed citations. Recurring topics across this work include Monoclonal and Polyclonal Antibodies Research (4 papers), Immunotherapy and Immune Responses (2 papers), Protein Degradation and Inhibitors (2 papers), Barrier Structure and Function Studies (2 papers), Cancer Cells and Metastasis (2 papers), Lung Cancer Treatments and Mutations (2 papers), PARP inhibition in cancer therapy (2 papers) and CAR-T cell therapy research (1 paper). The work is most often cited by research in Cancer Research (91 citations), Oncology (138 citations), Pulmonary and Respiratory Medicine (161 citations), Molecular Biology (132 citations) and Immunology (36 citations). Hobin Yang has collaborated with scholars based in South Korea, Ethiopia and China. Frequent co-authors include Young Kee Shin, Juan He, Naixin Liang, Hui Ren, Lifen Ren‐Heidenreich, Yifang Zhu, Wei Wang, Yanying Zheng, Kejing Tang and Bin Shi. Their work appears in journals such as Cancer Research and Treatment, Cancer Research, Pharmaceuticals, Laboratory Investigation and Frontiers in Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.